Skip to main content
. 2018 May 30;154(3):557–566. doi: 10.1016/j.chest.2018.05.015

Table 2.

Characteristics of Patients Who Received Either PPIs or H2Bs for at Least 3 Days During Their ICU Stay

Characteristic Bivariable Analyses
H2Bs (n = 20,517)
PPIs (n = 49,576)
P Value
Frequency or Mean Column % or SD Frequency or Mean Column % or SD
Outcome
 CIGIB 63 0.3 361 0.7 < .001
Sex
 Male 11,127 54.2 26,391 53.2 .007
Age, y
 18-60 8,505 41.5 18,648 37.6 < .001
 61-70 4,552 22.2 11,380 23
 71-80 4,316 21 11,130 22.5
 ≥ 81 3,144 15.3 8,418 17
Race
 White 15,271 74.4 37,952 76.6 < .001
 African American 1,997 9.7 5,985 12.1
 Hispanic 586 2.9 1,461 2.9
 Native American 112 0.5 405 0.8
 Asian 273 1.3 591 1.2
 Others 2,278 11.1 3,182 6.4
ICU type
 Mixed 12,165 59.3 20,933 42.2 < .001
 Cardiovascular-surgical 2,020 9.8 4,004 8.1
 Coronary care 2,907 14.2 10,139 20.5
 Trauma 166 0.8 154 0.3
 Surgical 1,065 5.2 4,809 9.7
 Medical 1,074 5.2 5,730 11.6
 Neuroscience 1,120 5.5 3,807 7.7
Nutrition
 No feeding 8,388 40.9 17,925 36.2 < .001
 Enteral nutrition 11,256 54.9 27,778 56
 Parenteral nutrition 144 0.7 578 1.2
 Both enteral nutrition and parenteral nutrition 729 3.6 3,295 6.6
Cancer 1,465 7.1 4,037 8.1 < .001
HIV 41 0.2 126 0.3 .154
Cirrhosis 120 0.6 697 1.4 < .001
Immunosuppression 507 2.5 1,882 3.8 < .001
Intubated in the first day 11,173 54.5 25,326 51.1 < .001
Risk factors
 Coagulopathy 4,724 23 13,804 27.8 < .001
 Mechanical ventilation > 24 h 12,686 61.8 29,668 59.8 < .001
 Traumatic brain injury 1,252 6.1 2,074 4.2 < .001
 Hepatic failure 78 0.4 512 1 < .001
 Hydrocortisone ≥ 250 md/d or equivalent 758 3.7 1,912 3.9 .536
 Transplantation 27 0.1 129 0.3 < .001
 Acute myocardial infarction 835 4.1 1,409 2.8 < .001
 Sepsis 4,422 21.6 13,814 27.9 < .001
 Neurologic injuries 3,823 18.6 6,672 13.5 < .001
 Surgical and multiple trauma 5,549 27 10,635 21.5 < .001
 Hypotension 5,060 24.7 13,689 27.6 < .001
 Acute renal failure 5,031 24.5 15,308 30.9 < .001
 Burns ≥ 30% BSA 12 0.1 8 0 .002
 ICU LOS > 7 d 7,270 35.4 19,337 39 < .001
Medication
 Sucralfate 302 1.5 1,402 2.8 < .001
 Antacids 7,237 35.3 16,747 33.8 .001
 Anticoagulants 11,500 56.1 28,014 56.5 .725
 Antiplatelets 12,848 62.6 30,409 61.3 .003
 Thrombolytics 1,877 9.1 3,755 7.6 < .001
 NSAIDs 10,805 52.7 26,024 52.5 .034
Admission source
 Chest pain center 82 0.4 188 0.4 < .001
 Direct admission 1,980 9.7 4,204 8.5
 ED 10,332 50.4 25,020 50.5
 Floor 2,580 12.6 8,662 17.5
 Operating room 3,984 19.4 7,603 15.3
 Other (other hospital or ICU, recovery room, step-down unit) 1,559 7.6 3,899 7.9
Year of admission
 2008 3,065 14.9 8,226 16.6 < .001
 2009 4,258 20.8 11,120 22.4
 2010 5,243 25.6 12,035 24.3
 2011 5,111 24.9 12,534 25.3
 2012 2,840 13.8 5,661 11.4
Physician specialty
 Internal medicine 2,307 11.2 9,708 19.6 < .001
 Pulmonary 4,025 19.6 8,170 16.5
 Hospitalist 1,378 6.7 5,169 10.4
 Cardiology 1,710 8.3 3,362 6.8
 Surgery-general 1,477 7.2 3,241 6.5
 Critical care medicine 1,827 8.9 3,357 6.8
 Family practice 959 4.7 3,138 6.3
 Surgery-cardiac 1,370 6.7 2,042 4.1
 Others 5,464 26.6 11,389 23
Teaching hospital 9,726 47.4 11,467 23.1 < .001
APACHE-IV score 66 26.82 69 26.93 < .001
Platelet counts 161 78.84 154 85.57 < .001

APACHE-IV = Acute Physiology and Chronic Health Evaluation version IV; BSA = body surface area; NSAIDs = nonsteroidal antiinflammatory drugs. See Table 1 legend for expansion of other abbreviations.